Skip to content

Investigating the effect of quince paste on the treatment of anorexia

Investigating the effect of quince paste on nausea, vomiting, and appetite in children with lymphoma under chemotherapy

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
IRCT
Registry ID
IRCT20240514061792N1
Enrollment
80
Registered
2024-07-14
Start date
2024-07-22
Completion date
Unknown
Last updated
2024-07-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Nausea and vomiting in lymphoma. Lymphoid leukemia

Interventions

Intervention 1: Intervention group: The study subjects are children aged 5 to 18 with malignancy who will be hospitalized for a minimum of 3 days at Shahid Sadoughi Hospital in Yazd to undergo chemoth

Sponsors

Yazd University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All
Age
5 Years to 18 Years

Inclusion criteria

Inclusion criteria: Age 5 to 18 years Definitive diagnosis of lymphoma Hospitalization for at least 3 days for chemotherapy Maximum daily activity score (ECOG) 2

Exclusion criteria

Exclusion criteria: Being under enteral or parenteral nutrition (partially or completely) History of allergy to quince and occurrence of allergic symptoms related to after consumption Abdominal or pelvic radiation therapy one week before the start of the study Occurrence of vomiting 24 hours before the start of chemotherapy

Design outcomes

Primary

MeasureTime frame
Level of nausea. Timepoint: 6 times a day after the start of the intervention. Method of measurement: Baxer animated retching faces.;Appetite level. Timepoint: 6 times a day after the start of the intervention. Method of measurement: Visual analog scale (VAS).;Hunger level. Timepoint: Daily after starting intervention. Method of measurement: Visual analog scale.;Level of fullness. Timepoint: Daily after starting intervention. Method of measurement: Visual analog scale.;Vomiting episodes. Timepoint: Daily after starting intervention. Method of measurement: Criteria for Adverse Events (CTCAE).

Secondary

MeasureTime frame
Height. Timepoint: Before the intervention, 3 days after the intervention. Method of measurement: Tape measure.;Weight. Timepoint: Before the intervention, 3 days after the intervention. Method of measurement: Weighting scale.;Body Mass Index (BMI). Timepoint: Before the intervention, 3 days after the intervention. Method of measurement: Formula.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactVida Shamsaddini Nargani

Yazd University of Medical Sciences

vidashams2000@gmail.com+98 35 3149 2228

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026